Skip to main content

Capital Analysts, LLC

SEC CIK
0001624758
Latest filing
Aug 5, 2026

ELV holding history

Elevance Health, Inc. in every 13F filed by Capital Analysts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overviewAll 13F holders of ELVFull Q2 2026 holdings

Shares (Q2 2026)
743
Value
$287.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ELV by Capital Analysts, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026743$287.0K<0.1%00.0%UnchangedHolders
Q1 2026743$218.0K<0.1%−29−3.8%ReducedHolders
Q4 2025772$271.0K<0.1%00.0%UnchangedHolders
Q3 2025772$250.0K<0.1%+194+33.6%AddedHolders
Q2 2025578$225.0K<0.1%+1+0.2%AddedHolders
Q1 2025577$251.0K<0.1%+35+6.5%AddedHolders
Q4 2024542$200.0K<0.1%−21,071−97.5%ReducedHolders
Q3 202421,613$11.2M0.5%+100.0%AddedHolders
Q2 202421,603$11.7M0.5%+654+3.1%AddedHolders
Q1 202420,949$10.9M0.5%+83+0.4%AddedHolders
Q4 202320,866$9.84M0.5%+254+1.2%AddedHolders
Q3 202320,612$8.97M0.5%+1,367+7.1%AddedHolders
Q2 202319,245$8.55M0.5%+851+4.6%AddedHolders
Q1 202318,394$8.46M0.5%+108+0.6%AddedHolders
Q4 202218,286$9.38M0.6%+84+0.5%AddedHolders
Q3 202218,202$8.27M0.6%+1,385+8.2%AddedHolders
Q2 202216,817$8.12M0.6%+244+1.5%AddedHolders
Q1 202216,573$8.14M0.5%+481+3.0%AddedHolders
Q4 202116,092$7.46M0.5%+362+2.3%AddedHolders
Q3 202115,730$5.86M0.4%+298+1.9%AddedHolders
Q2 202115,432$5.89M0.4%+614+4.1%AddedHolders
Q1 202114,818$5.32M0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.